Search research articles
Contact Us
Filters
Showing results (171-180 of 182) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 12, 2024
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study
Guopan Yu, Yu Zhang, Sijian Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 9, 2022
Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial
Haiyan Zhang, Zhiping Fan, Fen Huang, et al.
JAMA Network Open
|
July 7, 2021
Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and Outcomes
Sijian Yu, Zhiping Fan, Liping Ma, et al.
Journal of Internal Medicine
|
October 29, 2023
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3-ITD: A multicenter phase 2 study
Sijian Yu, Yu Zhang, Guopan Yu, et al.
Leukemia
|
November 10, 2020
IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells
Zhiwu Jiang, Rui Liao, Jiang Lv, et al.
Signal Transduction and Targeted Therapy
|
September 13, 2023
Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study
Ruoyang Shao, Yu Zhang, Jinping He, et al.
Experimental Hematology & Oncology
|
July 7, 2026
Autologous transplant versus matched sibling donor transplant in intermediate-risk AML in CR1 with no detectable MRD: a biological assignment comparative study
Sijian Yu, Hui Liu, Weihua Zhao, et al.
Medical Image Analysis
|
June 12, 2025
Evaluation of techniques for automated classification and artery quantification of the circle of Willis on TOF-MRA images: The CROWN challenge
Iris N Vos, Ynte M Ruigrok, Edwin Bennink, et al.
Medical Image Analysis
|
May 8, 2026
Multi-structure segmentation in CBCT volumes: The ToothFairy2 challenge
Federico Bolelli, Luca Lumetti, Niels van Nistelrooij, et al.
Leukemia
|
May 28, 2025
High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial
Yu Zhang, Zinan Feng, Jing Du, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 182) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 12, 2024
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study
Guopan Yu, Yu Zhang, Sijian Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 9, 2022
Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial
Haiyan Zhang, Zhiping Fan, Fen Huang, et al.
JAMA Network Open
|
July 7, 2021
Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and Outcomes
Sijian Yu, Zhiping Fan, Liping Ma, et al.
Journal of Internal Medicine
|
October 29, 2023
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3-ITD: A multicenter phase 2 study
Sijian Yu, Yu Zhang, Guopan Yu, et al.
Leukemia
|
November 10, 2020
IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells
Zhiwu Jiang, Rui Liao, Jiang Lv, et al.
Signal Transduction and Targeted Therapy
|
September 13, 2023
Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study
Ruoyang Shao, Yu Zhang, Jinping He, et al.
Experimental Hematology & Oncology
|
July 7, 2026
Autologous transplant versus matched sibling donor transplant in intermediate-risk AML in CR1 with no detectable MRD: a biological assignment comparative study
Sijian Yu, Hui Liu, Weihua Zhao, et al.
Medical Image Analysis
|
June 12, 2025
Evaluation of techniques for automated classification and artery quantification of the circle of Willis on TOF-MRA images: The CROWN challenge
Iris N Vos, Ynte M Ruigrok, Edwin Bennink, et al.
Medical Image Analysis
|
May 8, 2026
Multi-structure segmentation in CBCT volumes: The ToothFairy2 challenge
Federico Bolelli, Luca Lumetti, Niels van Nistelrooij, et al.
Leukemia
|
May 28, 2025
High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial
Yu Zhang, Zinan Feng, Jing Du, et al.
Page
of 19